Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Comment by SPCEO1on Sep 30, 2022 11:34am
168 Views
Post# 34997604

RE:RE:RE:Waiting to discuss P1 on Oct 13 will not be a good sign

RE:RE:RE:Waiting to discuss P1 on Oct 13 will not be a good signTHTX spent  the month of September getting out and telling their story and look what happened - the stock jumped higher despite very nasty overall market conditions. I don't know when they might share some positive news on TH-1902, or how positive it might be, but the fact they are out and about telling their story, which is a good one that offers the real potential of sizable upside, tells us which way the wind is blowing with TH-1902. Maybe we get news of proof of concept being established first orperhaps TH tells us they have filed for a protocol extension or that they have recieved such an extension from the FDA. But the indications are the company's sails are filling up and hopefully that will contnue to translate into better performance for THTX like we have already seen so far in September (THTX up 10% and the S&P 500 down over 7%). 

Biobob wrote: But you are right that anything material has to be announced as it becomes news and waiting for the 13th in that sense does imply they have nothing material to announce atm.. and that would be viewd negatively until then.. the expectations if you are listening Th is that you have something material soon... that's whats out there now from what the latest market action has been telling us.


<< Previous
Bullboard Posts
Next >>